Showing 1 - 10 of 78
This paper addresses the relationship between patent protection and investment in the development of new pharmaceutical treatments. The TRIPS Agreement, which specifies minimum levels of intellectual property protection for countries in the World Trade Organization, has increased levels of...
Persistent link: https://www.econbiz.de/10009002387
food-borne disease, our model also makes predictions regarding health outcomes. We find that child-mortality patterns …
Persistent link: https://www.econbiz.de/10005016242
This paper investigates the robustness of recent findings on the effect of parental background on child health. We are … particularly concerned with the extent to which their finding that income effects on child health are the result of spurious … and child health are correlated with some common unobservable (say, low parental time preference) then least squares …
Persistent link: https://www.econbiz.de/10005504391
The main objective of this paper is to provide estimates of the cost of moving out of subsistence for Madagascar …
Persistent link: https://www.econbiz.de/10005662377
Commodity prices are usually very slow to recover from adverse shocks. This is one of the reasons why it has proven so difficult either to smooth their effect or to stabilize them, and why it is sometimes argued that they should behave as if shocks were permanent. There is no reason however why...
Persistent link: https://www.econbiz.de/10005656239
pharmaceuticals, specifically drug reformulation regulatory gaming. …
Persistent link: https://www.econbiz.de/10009205060
pharmaceuticals. We challenge this orthodox view and show, to the contrary, that the pace of innovation often is faster in a world …
Persistent link: https://www.econbiz.de/10005666872
the hypothesis that innovation in pharmaceuticals is becoming more difficult and expensive over time, as costs of …
Persistent link: https://www.econbiz.de/10009003149
creating an internal market for pharmaceuticals can be analysed. In a model of third-degree price discrimination, arbitrage … Market in pharmaceuticals are ambiguous, since a movement from segmented and price-controlled markets towards integrated …
Persistent link: https://www.econbiz.de/10005114350
Preventives are sold ex ante, before disease status is realized, while treatments are sold ex post. Even if the mean of the ex ante distribution of consumer values is the same as that ex post, the shape of the distributions may differ, generating a difference between the surplus each product can...
Persistent link: https://www.econbiz.de/10011196028